Jason Drew Smith, General Counsel at UroGen Pharma Ltd. (URGN), sold 15,044 shares at $19.14 ($288K) on 2025-07-28, disclosed to the SEC on 2025-07-30.
Open-market sale of $288k URGN by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.14 | 7,522 | $144K | 50.0% |
| 2 | $19.14 | 7,522 | $144K | 50.0% |
| Total | $19.14 avg | 15,044 | $288K | 100% |
| Filing → |
| URGN | SELL | 2025-09-09 | $29K | — | Filing → |
| URGN | SELL | 2025-02-04 | $82K | — | Filing → |
| URGN | SELL | 2024-09-12 | $20K | — | Filing → |